2025 India Anti-Infective Vaccines Market Revenue Opportunities Report
Description
The 2025 India Anti-Infective Vaccines Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Anti-Infective Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the anti-infective vaccines market in India are Serum Institute of India, Bharat Biotech, Dr. Reddy’s Laboratories, and Zydus Lifesciences. Serum Institute of India, based in Pune, is the world's largest vaccine manufacturer by volume and produces key COVID-19 vaccines such as Covishield in collaboration with AstraZeneca. Bharat Biotech, headquartered in Hyderabad, developed the indigenous COVID-19 vaccine Covaxin and has expanded its annual production capacity to 700 million doses. Dr. Reddy’s Laboratories manufactures the Sputnik V vaccine in India under license from Russia’s Gamaleya Research Institute. Zydus Lifesciences has also developed and distributed COVID-19 vaccines actively in India.
These companies leverage India's vast vaccine manufacturing capabilities to supply both domestic and global markets. Serum Institute and Bharat Biotech lead production of major vaccines, while Dr. Reddy’s and Zydus contribute through licensed and indigenous vaccines. Additionally, Indian pharma giants such as Sun Pharmaceutical, Cipla, and Aurobindo Pharma dominate the broader pharmaceutical market, including anti-infectives, though their role in vaccines is less prominent compared to the above four. Collectively, these firms position India as a global hub for vaccine innovation and supply, with regulatory support from Indian health authorities ensuring safety and efficacy.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Anti-Infective Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the anti-infective vaccines market in India are Serum Institute of India, Bharat Biotech, Dr. Reddy’s Laboratories, and Zydus Lifesciences. Serum Institute of India, based in Pune, is the world's largest vaccine manufacturer by volume and produces key COVID-19 vaccines such as Covishield in collaboration with AstraZeneca. Bharat Biotech, headquartered in Hyderabad, developed the indigenous COVID-19 vaccine Covaxin and has expanded its annual production capacity to 700 million doses. Dr. Reddy’s Laboratories manufactures the Sputnik V vaccine in India under license from Russia’s Gamaleya Research Institute. Zydus Lifesciences has also developed and distributed COVID-19 vaccines actively in India.
These companies leverage India's vast vaccine manufacturing capabilities to supply both domestic and global markets. Serum Institute and Bharat Biotech lead production of major vaccines, while Dr. Reddy’s and Zydus contribute through licensed and indigenous vaccines. Additionally, Indian pharma giants such as Sun Pharmaceutical, Cipla, and Aurobindo Pharma dominate the broader pharmaceutical market, including anti-infectives, though their role in vaccines is less prominent compared to the above four. Collectively, these firms position India as a global hub for vaccine innovation and supply, with regulatory support from Indian health authorities ensuring safety and efficacy.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
